Tuesday, December 1, 2020
Equity Corporate Actions Alert #2020 - 231
(UPDATED: Business combination closed) Information Regarding the Business Combination of Neurotrope, Inc. (NTRP) & Petros Pharmaceuticals, Inc.
Category:
Markets Impacted:Contact Information:
Resources: |
The business combination of Neurotrope, Inc. (NTRP) and Petros Pharmaceuticals, Inc. has closed. As a result the Common Stock will be suspended from trading. In anticipation of the closing, the stock was halted immediately following the after-hours session at 8 p.m. on December 1, 2020. The stock will remain halted on the day of closing (December 2nd) and will be suspended effective December 3, 2020. The details are as follows:
Email Alert Subscriptions: Please follow Nasdaq on Facebook RSS and Twitter. Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com. |
---|